Lemmer J H, Botham M J, Orringer M B
J Thorac Cardiovasc Surg. 1985 Dec;90(6):849-55.
Seventy adult patients with thoracic empyema were treated at the University of Michigan Medical Center between 1978 and 1982. Twenty-two (31%) of the empyemas were associated with pneumonia, 23 (33%) occurred as postoperative complications, and seven (10%) were iatrogenic. When used as the initial mode of drainage, repeat thoracentesis was successful in only four of 11 cases (36%). Similarly, closed tube thoracostomy, as initial treatment, was successful in only 14 of 40 cases (35%). Rib resection, however, provided cure or control in 10 of 11 patients (91%) when employed as the first treatment method. Eight of 12 patients (67%) with parapneumonic empyemas were treated successfully with closed tube thoracostomy, in contrast to only two of 17 patients (12%) with postoperative empyemas so treated. Eventual control or cure of empyema was achieved in 57 patients (81%), whereas 13 (19%) died (five from their empyema and eight with empyema as an active problem at the time of death). All of the five empyema-caused deaths occurred in patients who underwent chest tube drainage as the most invasive treatment modality. The mortality rate for immunosuppressed patients was 40% (four of 10 patients). This analysis of a large recent series of adult empyemas suggests that chest tube drainage is often inadequate and more aggressive management is likely to result in fewer treatment failures and fewer total procedures. Early rib resection, especially for postoperative empyemas and those in immunocompromised patients, is recommended.
1978年至1982年间,密歇根大学医学中心对70例成年脓胸患者进行了治疗。其中22例(31%)脓胸与肺炎相关,23例(33%)为术后并发症,7例(10%)为医源性。作为初始引流方式时,重复胸腔穿刺术在11例患者中仅4例(36%)成功。同样,闭式胸腔引流作为初始治疗,在40例患者中仅14例(35%)成功。然而,当采用肋骨切除术作为首选治疗方法时,11例患者中有10例(91%)治愈或病情得到控制。12例肺炎旁胸腔积液患者中有8例(67%)通过闭式胸腔引流成功治愈,相比之下,17例术后脓胸患者中只有2例(12%)采用此方法成功治愈。57例患者(81%)最终病情得到控制或治愈,13例(19%)死亡(5例死于脓胸,8例死亡时脓胸为活跃问题)。所有5例因脓胸死亡的患者均接受了胸腔闭式引流作为最具侵入性的治疗方式。免疫抑制患者的死亡率为40%(10例患者中有4例)。对近期一系列大量成年脓胸病例的分析表明,胸腔闭式引流往往不够充分,更积极的治疗可能会减少治疗失败次数和总体手术量。建议早期进行肋骨切除术,尤其是对于术后脓胸患者和免疫功能低下患者。